Skip to main navigation Skip to search Skip to main content

Phase II Trial of Combination of Bortezomib and Rituximab in Relapsed and/or Refractory Waldenstrom Macroglobulinemia

  • Irene M. Ghobrial
  • , Jeffrey Matous
  • , Swaminathan Padmanabhan
  • , Ashraf Badros
  • , Robert Schlossman
  • , Stacey Chuma
  • , Renee Leduc
  • , Marybeth Nelson
  • , Kelly O’Connor
  • , Amy Sam
  • , Brianna Harris
  • , Jacob Soumerai
  • , Diane Warren
  • , Ann Birner
  • , Nikhil Munshi
  • , Steven P. Treon
  • , Kenneth C. Anderson
  • , Paul Richardson
  • Harvard University
  • Rocky Mountain Cancer Center, Denver, CO, USA
  • Roswell Park Cancer Institute
  • University of Maryland, Baltimore

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalBlood
Volume112
Issue number11
DOIs
StatePublished - Nov 16 2008
Externally publishedYes

Disciplines

  • Medicine and Health Sciences
  • Gastroenterology
  • Surgery
  • Internal Medicine

Cite this